Review
doi: 10.1016/j.ctrv.2008.10.008.
Epub 2009 Jan 19.
Therapeutic options for elderly patients with advanced non-small cell lung cancer
Affiliations
- PMID: 19155139
- DOI: 10.1016/j.ctrv.2008.10.008
Item in Clipboard
Review
Therapeutic options for elderly patients with advanced non-small cell lung cancer
Cancer Treat Rev.
2009 Jun.
Abstract
Elderly patients with advanced non-small cell lung cancer (NSCLC) are at higher risk for adverse events related to treatment of their disease. Chemotherapeutic agents used alone or together may increase survival, while leading to increased treatment related morbidity. New targeted agents used to treat NSCLC have yet to show sufficient improvement in disease outcomes. This review will discuss the current management of elderly patients with advanced non-small cell lung cancer.
Similar articles
-
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.J Clin Oncol. 2005 May 1;23(13):3125-37. doi: 10.1200/JCO.2005.00.224. J Clin Oncol. 2005. PMID: 15860872 Review.
-
Pemetrexed in first-line treatment of non-small cell lung cancer.Cancer Treat Rev. 2009 Jun;35(4):364-73. doi: 10.1016/j.ctrv.2009.02.002. Epub 2009 Mar 6. Cancer Treat Rev. 2009. PMID: 19269106 Review.
-
Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?J Clin Oncol. 2009 Jul 10;27(20):3268-70. doi: 10.1200/JCO.2009.22.4345. Epub 2009 May 26. J Clin Oncol. 2009. PMID: 19470913 No abstract available.
-
Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.Curr Opin Oncol. 2012 Mar;24(2):130-6. doi: 10.1097/CCO.0b013e32834ea6ea. Curr Opin Oncol. 2012. PMID: 22314616 Review.
-
Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.J Clin Oncol. 2005 Dec 20;23(36):9113-9. doi: 10.1200/JCO.2005.03.7465. J Clin Oncol. 2005. PMID: 16361618
Cited by
-
MicroRNA‑128‑b regulates epidermal growth factor receptor expression in non‑small cell lung cancer.Mol Med Rep. 2019 Dec;20(6):4803-4810. doi: 10.3892/mmr.2019.10731. Epub 2019 Oct 8. Mol Med Rep. 2019. PMID: 31638205 Free PMC article.
-
Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma.J Thorac Dis. 2018 Sep;10(9):5384-5393. doi: 10.21037/jtd.2018.08.64. J Thorac Dis. 2018. PMID: 30416786 Free PMC article.
-
Erlotinib plus capecitabine as first-line treatment for older Chinese patients with advanced adenocarcinoma of the lung (C-TONG0807): an open-label, single arm, multicenter phase II study.Medicine (Baltimore). 2015 Jan;94(2):e249. doi: 10.1097/MD.0000000000000249. Medicine (Baltimore). 2015. PMID: 25590835 Free PMC article. Clinical Trial.
-
EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab.Biologics. 2009;3:215-24. Epub 2009 Jul 13. Biologics. 2009. PMID: 19707410 Free PMC article.
-
Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adenocarcinoma cells.Daru. 2012 Oct 30;20(1):69. doi: 10.1186/2008-2231-20-69. Daru. 2012. PMID: 23351548 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
